Venturis Therapeutics

Venturis Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing novel therapies for diseases such as diabetes, severe ischemic heart disease, and peripheral artery disease. Their preclinical therapeutic programs include erectile dysfunction, occlusive stroke, degenerative disc disease, and Parkinson's disease. Venturis Therapeutics focuses on the targeted delivery of next-generation molecules, which will improve the quality of life for patients with vascular dysfunction.